NO20040469L - Heterocykliske forbindelser samt fremstilling og anvendelse derav - Google Patents

Heterocykliske forbindelser samt fremstilling og anvendelse derav

Info

Publication number
NO20040469L
NO20040469L NO20040469A NO20040469A NO20040469L NO 20040469 L NO20040469 L NO 20040469L NO 20040469 A NO20040469 A NO 20040469A NO 20040469 A NO20040469 A NO 20040469A NO 20040469 L NO20040469 L NO 20040469L
Authority
NO
Norway
Prior art keywords
preparation
heterocyclic compounds
heterocyclic
compounds
Prior art date
Application number
NO20040469A
Other languages
English (en)
Other versions
NO329434B1 (no
Inventor
Rene Lenobel
Miroslav Strnad
Karel Dolezal
Lgor Popa
Jan Holub
Stefaan Werbrouock
Marek Zatloukal
Original Assignee
Ustav Ex Botan Akademie Ved Ce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ustav Ex Botan Akademie Ved Ce filed Critical Ustav Ex Botan Akademie Ved Ce
Publication of NO20040469L publication Critical patent/NO20040469L/no
Publication of NO329434B1 publication Critical patent/NO329434B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
NO20040469A 2001-08-02 2004-02-02 Anvendelse av 6-(4-hydroksybenzylamino)purin til kosmetiske formal NO329434B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20012818A CZ294535B6 (cs) 2001-08-02 2001-08-02 Heterocyklické sloučeniny na bázi N6-substituovaného adeninu, způsoby jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
PCT/CZ2002/000045 WO2003040144A2 (en) 2001-08-02 2002-08-01 Heterocyclic compound based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds

Publications (2)

Publication Number Publication Date
NO20040469L true NO20040469L (no) 2004-04-30
NO329434B1 NO329434B1 (no) 2010-10-18

Family

ID=5473504

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040469A NO329434B1 (no) 2001-08-02 2004-02-02 Anvendelse av 6-(4-hydroksybenzylamino)purin til kosmetiske formal

Country Status (20)

Country Link
US (2) US7279482B2 (no)
EP (1) EP1419157B1 (no)
JP (1) JP2005508386A (no)
KR (1) KR100939147B1 (no)
CN (1) CN1556808B (no)
AU (3) AU2002363362B2 (no)
BR (1) BR0211597A (no)
CA (1) CA2455972C (no)
CZ (1) CZ294535B6 (no)
HU (1) HUP0401407A3 (no)
IL (1) IL160136A0 (no)
MX (1) MXPA04000936A (no)
NO (1) NO329434B1 (no)
NZ (1) NZ531086A (no)
PL (1) PL368299A1 (no)
RS (1) RS52389B (no)
RU (1) RU2302421C2 (no)
SG (2) SG127738A1 (no)
WO (1) WO2003040144A2 (no)
ZA (1) ZA200401461B (no)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60118521T2 (de) * 2000-01-07 2006-10-12 Universitaire Instelling Antwerpen Purin derivate, ihre herstellung und verwendung
FR2818642B1 (fr) * 2000-12-26 2005-07-15 Hoechst Marion Roussel Inc Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilistion
CZ294535B6 (cs) * 2001-08-02 2005-01-12 Ústav Experimentální Botaniky Avčr Heterocyklické sloučeniny na bázi N6-substituovaného adeninu, způsoby jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
US7273864B2 (en) * 2002-10-15 2007-09-25 The Scripps Research Institute Compositions and methods for inducing osteogenesis
MXPA06001758A (es) * 2003-08-15 2006-08-11 Irm Llc Anilino purinas sustituidas en la posicion 6 utiles como inhibidores de rtk.
AU2011213790B2 (en) * 2003-10-03 2013-05-02 The General Hospital Corporation Methods for altering mRNA splicing and treating familial dysautonomia and other mechanistically related disorders
EP1673439B1 (en) * 2003-10-03 2017-12-06 The General Hospital Corporation Compositions for treating familial dysautonomia by altering mrna splicing
MX2009007944A (es) * 2007-01-26 2009-08-07 Irm Llc Compuestos y composiciones de purina como inhibidores de quinasa para el tratamiento de enfermedades relacionadas con plasmodium.
US20100105705A1 (en) * 2007-03-28 2010-04-29 Neurosearch A/S Purinyl derivatives and their use as potassium channel modulators
CZ302225B6 (cs) * 2007-07-04 2010-12-29 Univerzita Palackého v Olomouci Substituované 6-anilinopurinové deriváty jako inhibitory cytokinin oxidasy a prípravky obsahující tyto slouceniny
CZ300774B6 (cs) * 2007-10-05 2009-08-05 Univerzita Palackého Substituované 6-(alkylbenzylamino)purinové deriváty pro použití jako antagonisté cytokininových receptoru a prípravky obsahující tyto slouceniny
ES2734288T3 (es) * 2007-11-28 2019-12-05 Dana Farber Cancer Inst Inc Inhibidores de miristato de moléculas pequeñas de Bcr-abl y métodos de uso
CZ302623B6 (cs) 2009-04-22 2011-08-03 Univerzita Palackého Oxalátokomplexy platiny s deriváty N6-benzyladeninu, zpusob jejich prípravy a použití techto komplexu jako léciv v protinádorové terapii
EP2845856A1 (en) 2009-06-29 2015-03-11 Incyte Corporation Pyrimidinones as PI3K inhibitors
CZ302618B6 (cs) 2009-09-10 2011-08-03 Univerzita Palackého Cyklobutan-1,1-dikarboxylátokomplexy platiny s deriváty N6-benzyladeninu, zpusoby jejich prípravy a použití techto komplexu jako léciv v protinádorové terapii
ME02020B (me) * 2009-09-29 2015-05-20 Univ Texas Anti-malarijski agensi kao inhibitori dihidroorotat dehidrogenaze
US8759359B2 (en) * 2009-12-18 2014-06-24 Incyte Corporation Substituted heteroaryl fused derivatives as PI3K inhibitors
WO2011075630A1 (en) * 2009-12-18 2011-06-23 Incyte Corporation Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors
EP2558463A1 (en) 2010-04-14 2013-02-20 Incyte Corporation Fused derivatives as i3 inhibitors
RU2438311C1 (ru) * 2010-06-09 2012-01-10 Государственное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" (ГОУ ВПО "КубГТУ") 3-пиперидинил-4-бензосульфамидобутиролактон, проявляющий корнеобразующую активность на семенах озимой пшеницы
WO2011163195A1 (en) 2010-06-21 2011-12-29 Incyte Corporation Fused pyrrole derivatives as pi3k inhibitors
CZ2010670A3 (cs) * 2010-09-07 2012-03-14 Univerzita Palackého v Olomouci Použití 6-substituovaných 9-halogenalkyl purinu pro regulaci rustu a vývoje rostlin, rostlinných orgánu a bunek, nové 6-substituované 9-halogenalkyl puriny
TW201249844A (en) 2010-12-20 2012-12-16 Incyte Corp N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
WO2012125629A1 (en) 2011-03-14 2012-09-20 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
US9126948B2 (en) 2011-03-25 2015-09-08 Incyte Holdings Corporation Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
WO2012142029A2 (en) 2011-04-10 2012-10-18 Florida A&M University Serms for the treatment of estrogen receptor-mediated disorders
UA121539C2 (uk) 2011-09-02 2020-06-25 Інсайт Холдинґс Корпорейшн Гетероцикліламіни як інгібітори рі3к
AR090548A1 (es) 2012-04-02 2014-11-19 Incyte Corp Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
WO2014066071A1 (en) 2012-10-26 2014-05-01 Exxonmobil Upstream Research Company Downhole flow control, joint assembly and method
CZ306894B6 (cs) 2013-02-08 2017-08-30 Univerzita PalackĂ©ho v Olomouci 2-Substituované-6-biarylmethylamino-9-cyklopentyl-9H-purinové deriváty, jejich použití jako léčiva a farmaceutické přípravky tyto sloučeniny obsahující
US9938279B2 (en) * 2013-04-09 2018-04-10 Energenesis Biomedical Co., Ltd Method for treating disease or condition susceptible to amelioration by AMPK activators and compounds of formula which are useful to activate AMP-activated protein kinase (AMPK)
RU2529817C1 (ru) * 2013-07-08 2014-09-27 Владимир Иванович Петров 9-[2-(4-изопропилфенокси)этил]аденин, обладающий антидепрессантным и противострессорным действием
US9816361B2 (en) 2013-09-16 2017-11-14 Exxonmobil Upstream Research Company Downhole sand control assembly with flow control, and method for completing a wellbore
CN108703970A (zh) * 2013-09-18 2018-10-26 华安医学股份有限公司 一种活化ampk的化合物及其用途
US10077277B2 (en) 2014-06-11 2018-09-18 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
CZ306984B6 (cs) 2014-12-15 2017-11-01 Ústav experimentální botaniky AV ČR, v. v. i. 6,8-Disubstituované-9-(heterocyklyl)puriny, přípravky obsahující tyto deriváty a jejich použití v kosmetických a medicínských aplikacích
PL3244891T3 (pl) * 2015-01-16 2022-12-27 The General Hospital Corporation Związki poprawiające splicing mRNA
UA122332C2 (uk) 2015-02-27 2020-10-26 Інсайт Корпорейшн Солі інгібітора pi3k і способи їх отримання
WO2016183063A1 (en) 2015-05-11 2016-11-17 Incyte Corporation Crystalline forms of a pi3k inhibitor
WO2016183060A1 (en) 2015-05-11 2016-11-17 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor
JP7082120B2 (ja) 2016-10-21 2022-06-07 ニンバス ラクシュミ， インコーポレイテッド Ｔｙｋ２阻害剤およびその使用
CN106632338B (zh) * 2016-12-16 2018-11-27 温州医科大学 一种9-取代-n-（2-氯苄基）嘌呤-6-胺类衍生物及其制备方法和应用
CN106632339B (zh) * 2016-12-16 2018-11-27 温州医科大学 一种6-取代-9h-嘌呤类衍生物及其制备方法和应用
CA3057978A1 (en) 2017-03-27 2018-10-04 The Regents Of The University Of California Compositions and method of treating cancer
CZ307868B6 (cs) 2017-04-28 2019-07-10 Univerzita PalackĂ©ho v Olomouci Deriváty 9-(2-oxacykloalkyl)-9H-purin-2,6-diaminu, přípravky obsahující tyto deriváty a jejich použití
JP6510621B2 (ja) * 2017-11-29 2019-05-08 華安醫學股分有限公司Ｅｎｅｒｇｅｎｅｓｉｓ Ｂｉｏｍｅｄｉｃａｌ Ｃｏ．， Ｌｔｄ． 活性化ａｍｐｋの化合物及びその使用
CN107903274A (zh) * 2017-12-28 2018-04-13 窦玉玲 一种胺类化合物及其在抗肿瘤药物中的应用
MX2020012826A (es) 2018-06-01 2021-03-09 Incyte Corp Regimen de dosificacion para el tratamiento de trastornos relacionados con fosfatidilinositol 3-cinasas (pi3k).
JP6877479B2 (ja) * 2019-04-04 2021-05-26 華安醫學股分有限公司Ｅｎｅｒｇｅｎｅｓｉｓ Ｂｉｏｍｅｄｉｃａｌ Ｃｏ．， Ｌｔｄ． 活性化ａｍｐｋの化合物及びその使用
CZ309368B6 (cs) * 2020-05-17 2022-10-12 Univerzita Palackého v Olomouci Mesylátové soli heterocyklických cytokininů, přípravky obsahující tyto deriváty a jejich použití
CZ2020277A3 (cs) 2020-05-17 2021-07-21 Ústav experimentální botaniky AV ČR, v. v. i. Mesylátová sůl para-topolinu, přípravky ji obsahující, a její použití
CN111777612B (zh) * 2020-06-05 2022-04-19 广东达元绿洲食品安全科技股份有限公司 一种6-苄基腺嘌呤半抗原、人工抗原及其在免疫检测中的应用
EP4178959B1 (en) 2020-07-13 2025-09-10 Univerzita Palackého v Olomouci Nitrogen heterocyclic cytokinin derivatives, compositions containing these derivatives and use thereof
CN112656800A (zh) * 2021-02-09 2021-04-16 中国科学院昆明动物研究所 巯嘌呤及其衍生物在制备解除恶性肿瘤免疫抑制药物中的用途
CZ310053B6 (cs) * 2022-01-31 2024-06-19 Univerzita Palackého v Olomouci Heterocyklické purinové deriváty cytokininů, jejich použití při hojení ran a farmaceutické kompozice obsahující tyto deriváty

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3041340A (en) * 1962-06-26 Method of preparing substituted
US2956998A (en) * 1960-10-18 Adenine derivatives and process
US3213095A (en) * 1963-04-04 1965-10-19 American Cyanamid Co N-benzylation of adenine
US3321293A (en) * 1964-04-29 1967-05-23 Union Carbide Corp Method of defoliating cotton plants
DE2401254A1 (de) * 1974-01-11 1975-11-27 Boehringer Mannheim Gmbh Neue derivate von n hoch 6-substituierten adeninen
JPH0690429B2 (ja) * 1986-05-26 1994-11-14 コニカ株式会社 直接ポジ型ハロゲン化銀写真感光材料
US5371089A (en) * 1987-02-26 1994-12-06 Senetek, Plc Method and composition for ameliorating the adverse effects of aging
US5164394A (en) * 1989-06-08 1992-11-17 Senetek, Plc Method for treating hyperproliferative skin diseases
ATE185272T1 (de) * 1991-05-16 1999-10-15 Senetek Plc Verfahren und zusammensetzung zur verbesserung der ungünstigen auswirkungen des alterns
AU659861B2 (en) * 1991-09-10 1995-06-01 Sansho Seiyaku Co., Ltd. Preparation for promoting hair growth
JP2636118B2 (ja) * 1991-09-10 1997-07-30 三省製薬株式会社 育毛剤
JPH07233037A (ja) * 1993-12-29 1995-09-05 Sansho Seiyaku Co Ltd 皮膚化粧料
EP0831829B1 (en) * 1995-06-07 2003-08-20 Pfizer Inc. Heterocyclic ring-fused pyrimidine derivatives
PT874846E (pt) * 1995-11-01 2003-08-29 Novartis Ag Derivados de purina e processos para a sua preparacao
US6498163B1 (en) * 1997-02-05 2002-12-24 Warner-Lambert Company Pyrido[2,3-D]pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation
DE60118521T2 (de) * 2000-01-07 2006-10-12 Universitaire Instelling Antwerpen Purin derivate, ihre herstellung und verwendung
CZ294535B6 (cs) * 2001-08-02 2005-01-12 Ústav Experimentální Botaniky Avčr Heterocyklické sloučeniny na bázi N6-substituovaného adeninu, způsoby jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
AU2003247667A1 (en) * 2002-07-01 2004-01-19 University Of Rochester Medical Center Method for determination of likelihood of occurrence of preterm labor in pregnant females

Also Published As

Publication number Publication date
SG127738A1 (en) 2006-12-29
BR0211597A (pt) 2004-07-13
CA2455972A1 (en) 2003-05-15
US20050043328A1 (en) 2005-02-24
CA2455972C (en) 2012-01-03
AU2002363362B2 (en) 2008-05-22
WO2003040144A2 (en) 2003-05-15
SG119228A1 (en) 2006-02-28
JP2005508386A (ja) 2005-03-31
YU8904A (sh) 2006-08-17
MXPA04000936A (es) 2005-02-17
RU2004105843A (ru) 2005-07-10
CZ294535B6 (cs) 2005-01-12
ZA200401461B (en) 2005-08-31
CN1556808B (zh) 2010-04-28
CZ20012818A3 (cs) 2003-03-12
EP1419157B1 (en) 2013-11-27
AU2008203838A1 (en) 2008-09-04
IL160136A0 (en) 2004-06-20
KR20050016267A (ko) 2005-02-21
WO2003040144A3 (en) 2004-02-26
AU2008203838B2 (en) 2011-09-01
AU2008203837A1 (en) 2008-09-04
KR100939147B1 (ko) 2010-01-28
PL368299A1 (en) 2005-03-21
US20080014227A1 (en) 2008-01-17
HUP0401407A3 (en) 2007-05-29
HUP0401407A2 (hu) 2004-11-29
CN1556808A (zh) 2004-12-22
US8552013B2 (en) 2013-10-08
US7279482B2 (en) 2007-10-09
RU2302421C2 (ru) 2007-07-10
NZ531086A (en) 2005-12-23
NO329434B1 (no) 2010-10-18
RS52389B (sr) 2013-02-28
EP1419157A2 (en) 2004-05-19

Similar Documents

Publication Publication Date Title
DK1400518T3 (da) Heterocycliske forbindelser og lægemidler
NO20042147L (no) Heterocykliske forbindelser og fremgangsmater for anvendelse derav
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
DK1122244T3 (da) Uracilforbindelser og anvendelse deraf
NO20041975D0 (no) Bicyklisk oksopyridin og oksopyrimidinderivater
EP1412378A4 (en) APTAMERS AND ANTIAPTAMERS
NO20024742D0 (no) Heterocykliske forbindelser, deres fremstilling og anvendelse
IS6934A (is) Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar
DK1233964T3 (da) Ny anvendelse og hidtil ukendte N-azabicycloamidderivater
ID26056A (id) Popok sekali pakai
ID26389A (id) Popok sekali pakai
ATE319451T1 (de) Tetrahydrochinolin-derivate
NO20033203L (no) Terapeutiske heterocykliske forbindelser
ATE312827T1 (de) 3-substituierte-4-pyrimidonderivate
NO20034159D0 (no) Östrogen-gestagen-kombinasjonspreparat og anvendelse derav
NO20025510L (no) Dibenzoazulen-derivater samt anvendelse derav
DK1106607T3 (da) Uracilforbindelser og anvendelse deraf
ID25571A (id) Popok sekali pakai
DE60223031D1 (de) Arylpiperazin gebundene tetrahydroindolonderivate
NO20013085D0 (no) Fosfororganiske forbindelser og deres anvendelse
FI112705B (fi) Saranat
DK1392670T3 (da) Substituerede C-furan-2-yl-methylamin- og C-thiophen-2-yl-methylamin-derivater
ID30381A (id) Penggunaan arilalkanoilpiridazina
DE60202381D1 (de) Paroxetin-n-formyl-derivate
DE10296144D2 (de) Koffer

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees